Monitoring glucose levels after kidney transplantation
Continuous Glucose Monitoring in Kidney Transplant Recipients with Diabetes, Pre-diabetes and Without Diabetes
This study looks at how glucose levels change in kidney transplant patients during the first two weeks after surgery to see if there are differences between those with diabetes, prediabetes, and no diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 54 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Copenhagen, DK) |
| Trial ID | NCT06675903 on ClinicalTrials.gov |
What this trial studies
This observational study investigates glucose levels in kidney transplant recipients using continuous glucose monitoring (CGM) within the first two weeks post-surgery. It focuses on three groups: patients with diabetes, prediabetes, and those without diabetes, analyzing differences in their glucose profiles. The study aims to understand how hyperglycaemia develops in these patients, particularly in relation to immunosuppression and steroid use. A total of 54 participants will be monitored to assess glucose indices and adherence to treatment guidelines.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are undergoing kidney transplantation and have varying glucose regulation statuses.
Not a fit: Patients who are unable to cooperate with CGM monitoring in the first ten days post-surgery or those with combined organ transplants may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of glucose levels in kidney transplant recipients, potentially reducing the risk of post-transplant diabetes and related complications.
How similar studies have performed: While there have been minor studies using CGM in similar contexts, this specific approach to monitoring glucose post-kidney transplantation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent obtained before CGM application * Male or female; age: ≥18 years * Kidney transplantation Exclusion Criteria: * Unable to cooperate to CGM the first ten days after surgery * Allergic to plasters in CGM units * Combined kidney and liver or pancreatic transplantation * Graft loss/rejection within first 48 hours after transplantation
Where this trial is running
Copenhagen, DK
- Rigshospitalet — Copenhagen, Dk, Denmark (Recruiting)
Study contacts
- Study coordinator: Ida S Voss, MD
- Email: Ida.voss@regionh.dk
- Phone: +4535457063
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.